ATRS

Antares Pharma, Inc.

Delisted

ATRS was delisted on the 23rd of May, 2022.

154 hedge funds and large institutions have $157M invested in Antares Pharma, Inc. in 2020 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 55 increasing their positions, 47 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
154
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$262K
Puts
$628K
Net Calls
Net Calls Change

Top Buyers

1 +$2.36M
2 +$2.04M
3 +$1.27M
4
SIG
Sargent Investment Group
Maryland
+$1.2M
5
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
+$1.11M

Top Sellers

1 -$6.36M
2 -$3.44M
3 -$2.55M
4
Deutsche Bank
Deutsche Bank
Germany
-$1.28M
5
Goldman Sachs
Goldman Sachs
New York
-$1.18M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$26.8M
2
$18.6M
3
$10.9M
4
$9.19M
5
$7.44M
6
$5.42M
7
$4.58M
8
$3.84M
9
$3.7M
10
$3.56M
11
$3.23M
12
$2.95M
13
$2.9M
14
$2.8M
15
$2.67M
16
$2.36M
17
$2.28M
18
$2.04M
19
$1.95M
20
$1.5M
21
$1.5M
22
$1.49M
23
$1.46M
24
$1.38M
25
$1.37M